Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison.
Adv Ther. 2024 Jun;41(6):2486-2499. doi: 10.1007/s12325-024-02856-3. Epub 2024 Apr 20.
Adv Ther. 2024.
PMID: 38642198
Free PMC article.
Clinical Trial.
Cite
Cite